Cardiac Biomarkers Market to Grow at 14.2% CAGR Through 2032 Amid Rising Demand for Early Detection and Point-of-Care Testing

Industry Experts, Inc. has released a comprehensive new market research report titled "Global Cardiac Biomarkers Market - Types, Applications and Testing Locations." According to the report, the global market for cardiac biomarkers is projected to rise from US$22.7 billion in 2025 to US$57.5 billion by 2032, expanding at a CAGR of 14.2% during the forecast period.

The global burden of cardiovascular disease continues to rise, driving strong demand for early, non-invasive diagnostics. Biomarkers such as troponins, BNP/NT-proBNP, and hs-CRP are essential for rapid triage, risk assessment, and treatment guidance in both acute and chronic settings. The market is benefiting from increased adoption of point-of-care platforms, personalized medicine, and AI-enhanced testing. North America leads with a 41.8% share in 2025, supported by clinical innovation and FDA-backed adoption, while Asia Pacific is the fastest-growing region, projected to register over 16% CAGR through 2032, led by China and India's expanding healthcare access and diagnostic capabilities.

Among biomarker types, troponins dominate with a 35% share in 2025, while BNP/NT-proBNP is the fastest-growing segment, supported by increasing incidence of heart failure and adoption in both emergency and outpatient care. By application, myocardial infarction leads the market, accounting for 41.6% of global demand, while acute coronary syndrome is set to post the highest CAGR at 15.4%. Laboratory testing remains the leading diagnostic location, but point-of-care testing is gaining rapid ground due to its speed and utility in decentralized settings.

The report covers the market across 14 independent countries spanning North America, Europe, Asia Pacific, South America, and Rest of World, and segments it by type, application, and location of testing. It also includes profiles of over 10 major companies including Abbott, Siemens Healthineers, Thermo Fisher Scientific, Danaher, Bio-Rad, Randox, QuidelOrtho, and Biomérieux. Strategic insights into emerging biomarkers, high sensitivity assays, and AI driven testing platforms are also featured.

For sample pages or purchase options, contact +1-320-497-3787 or visit Cardiac Biomarkers Market Report Page

About Industry Experts, Inc
Industry Experts, Inc. ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com

Comments

Popular posts from this blog

Demand for Europium to Reach US$373.3 million by 2030 Fostered by Phosphors and Consumer Electronic Applications

Copper Demand to Reach US$368.8 B by 2030 Propelled by the Wide Range of Applications of the Metal Across Sectors

Oil & Gas Fuels Demand for Duplex Stainless Steel and Global Market to Reach $6 billion by 2030